1. Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?

   • Ronald M. Bukowski

   Clinical Trial Report 03 February 2010 Pages: 77 - 79

2. RANK Ligand: Effects of Inhibition

   • Saby George
   • Andrew Brenner
   • Ronald M. Bukowski

   ReviewPaper 03 March 2010 Pages: 80 - 86

   

3. Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer

   • James M. Cleary
   • Geoffrey I. Shapiro

   ReviewPaper 09 March 2010 Pages: 87 - 94

   

4. Hsp90: A Drug Target?

   • Jeffrey M. Holzbeierlein
   • Andrew Windsperger
   • George Vielhauer

   OriginalPaper 13 February 2010 Pages: 95 - 101

5. Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors

   • Susan A. J. Vaziri
   • Jenny Kim
   • Ram Ganapathi

   OriginalPaper 23 February 2010 Pages: 102 - 108

   

6. Quality Initiatives in Head and Neck Cancer

   • Amy Y. Chen

   OriginalPaper 06 February 2010 Pages: 109 - 114

7. Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer

   • David J. Adelstein
   • Cristina P. Rodriguez

   OriginalPaper 04 February 2010 Pages: 115 - 120

8. Nanotechnology in Head and Neck Cancer: The Race Is On

   • Ivan H. El-Sayed

   ReviewPaper Open access 03 March 2010 Pages: 121 - 128

   

9. Oral Cavity Squamous Cell Carcinoma and the Clinically N0 Neck: The Past, Present, and Future of Sentinel Lymph Node Biopsy

   • Andrew Coughlin
   • Vicente A. Resto

   ReviewPaper 02 March 2010 Pages: 129 - 135

10. The Relationship Between Vitamin D and Breast Cancer Incidence and Natural History

    • Qamar J. Khan
    • Bruce F. Kimler
    • Carol J. Fabian

    OriginalPaper 17 February 2010 Pages: 136 - 142